EXCLI Journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.
EXCLI Journal (eISSN 1611-2156) is particularly keen to keep a broad view of science and technology, and therefore welcomes papers which bridge disciplines and may not suit the narrow specialism of other journals. Although the general emphasis is on biological sciences, studies from the following fields are explicitly encouraged:
aging research, cell biology, clinical and preclinical research, drug development, environmental health, ergonomics, gastroenterology and hepatology, genetics, epigenetics and genomics, immunology, neuroscience and behavioral sciences, oncology and cancer research, pharmacology and toxicology, physiology, biochemistry and metabolomics, psychology, regenerative medicine and stem cell research, systems biology
For new submissions to EXCLI Journal, please consult our updated Formal Requirements.
If you are submitting for the first time, the Tutorial on creating an account and the Tutorial on uploading your submissions guide you through the process of creating your submission.
Read more about Updated Author GuidelinesPublished continuously
Categories (from 2022 onwards)
Cancer Research Human Factors Immunology Life Sciences Neuroscience Pharmacology/Toxicology
Powered by
EXCLI Journal (eISSN 1611-2156) is a platinum open access journal. There are neither fees for authors submitting their papers nor fees for readers accessing PDFs of the published papers.
Articles published in EXCLI Journal are licensed under a Creative Commons Attribution 4.0 International License.
